Acute Coronary Syndrome (ACS) is a term used to describe a range of conditions associated with sudden, reduced blood flow to the heart muscle. It encompasses a spectrum of coronary artery diseases, including unstable angina and myocardial infarction (heart attack). ACS typically occurs when there is a rupture of an atherosclerotic plaque in a coronary artery, leading to the formation of a blood clot that partially or completely blocks blood flow to the heart. The hallmark symptoms of ACS include chest pain or discomfort, often radiating to the arms, neck, jaw, or back. Additional symptoms might involve difficulty breathing, feelings of nausea, and experiencing cold sweats. Recognizing and promptly treating ACS is critical, as it can lead to significant damage to the heart muscle, resulting in long-term complications or even death. Diagnosis involves a combination of clinical assessment, electrocardiograms (ECGs), blood tests to measure cardiac biomarkers and imaging studies. Immediate interventions, such as administering antiplatelet medications, nitroglycerin, and anticoagulants, aim to restore blood flow to the heart. In certain cases, procedures like angioplasty and stent placement or coronary artery bypass surgery may be necessary. Long-term management involves lifestyle modifications, medications, and cardiac rehabilitation to reduce the risk of recurrent events. ACS requires urgent medical attention, and individuals experiencing symptoms should seek immediate help to improve outcomes and prevent further damage to the heart.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States